Source: European Heart Journal. Unidade: FMRP
Assunto: DOENÇAS CARDIOVASCULARES (EPIDEMIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal, v. 21, p. 2033-2041, 2000Tradução . . Acesso em: 04 out. 2024.APA
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. (2000). The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal, 21, 2033-2041.NLM
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 2000 ; 21 2033-2041.[citado 2024 out. 04 ]Vancouver
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 2000 ; 21 2033-2041.[citado 2024 out. 04 ]
